hesperetin has been researched along with phosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maiti, K; Mukherjee, K; Mukherjee, PK; Murugan, V; Saha, BP | 1 |
| Boom, K; Borsoi, C; Celia, C; Ferrari, M; Fresta, M; Grande, R; Scott, B; Shen, H; Shen, J; Suri, K; Wolfram, J; Zhao, Y | 1 |
2 other study(ies) available for hesperetin and phosphatidylcholines
| Article | Year |
|---|---|
Exploring the effect of Hesperetin-HSPC complex--a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics.
Topics: Animals; Antioxidants; Calibration; Carbon Tetrachloride Poisoning; Chemistry, Pharmaceutical; Drug Delivery Systems; Glycine max; Hesperidin; Liver Function Tests; Male; Phosphatidylcholines; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Solubility; Suspensions | 2009 |
Hesperetin Liposomes for Cancer Therapy.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Compounding; Drug Resistance, Neoplasm; Female; Hesperidin; Humans; Kinetics; Liposomes; Lung Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Solubility; Transfection | 2016 |